Table 2 Postinterventional Survival: Analysis of Potential Clinical and Echocardiographic Predictors.
Parameter | Unadjusted HR (95% CI) | Unadjusted P - Value | Adjusted* HR (95% CI) | Adjusted* P - Value | Partial*** PEV % |
|---|---|---|---|---|---|
Aortic regurgitation severity | 0.71 (0.27–1.90) | 0.499 | 0.86 (0.32–2.31) | 0.767 | 0.0 |
Body mass index | 1.02 (0.95–1.09) | 0.660 | 1.03 (0.96–1.11) | 0.414 | 0.0 |
Coronary artery disease | 0.88 (0.37–2.09) | 0.772 | 0.58 (0.23–1.48) | 0.257 | 3.9 |
LV ejection fraction | 1.04 (0.92–1.17) | 0.562 | 1.03 (0.90–1.18) | 0.644 | 0.0 |
Hypercholesterolemia | 1.23 (0.54–2.80) | 0.614 | 1.19 (0.52–2.71) | 0.687 | 0.1 |
Hypertension | 0.76 (0.34–1.72) | 0.512 | 0.68 (0.30–1.55) | 0.357 | 0.7 |
Aortic valve area** | 1.07 (0.77–1.49) | 0.676 | 1.21 (0.86–1.72) | 0.273 | 1.5 |
Peak aortic jet velocity** | 0.88 (0.81–0.96) | 0.005 | 0.91 (0.82–1.00) | 0.050 | 4.7 |
Atrial fibrillation vs. SR | 1.14 (0.46–2.82) | 0.774 | 1.09 (0.44–2.70) | 0.846 | 1.2 |
PM vs. SR | 1.59 (0.52–4.86) | 0.419 | 1.61 (0.53–4.93) | 0.406 | |
Left atrial diameter | 1.02 (0.97–1.06) | 0.446 | 1.02 (0.97–1.07) | 0.520 | 2.7 |
Moderate-to-severe MR | 1.06 (0.46–2.40) | 0.898 | 1.39 (0.58–3.35) | 0.461 | 2.2 |
Neurologic dysfunction | 0.89 (0.12–6.72) | 0.914 | 0.75 (0.10–5.66) | 0.779 | 0.3 |
Peripheral artery disease | 0.94 (0.41–2.17) | 0.885 | 0.47 (0.18–1.20) | 0.114 | 5.9 |
Right ventricular dysfunction | 2.89 (1.22–6.84) | 0.016 | 2.27 (0.88–5.87) | 0.090 | 5.5 |
Moderate-to-severe TR | 3.48 (1.47–8.27) | 0.003 | 3.40 (1.38–8.35) | 0.008 | 10.7 |
Diabetes | 2.17 (0.96–4.94) | 0.064 | 1.94 (0.84–4.46) | 0.118 | 2.9 |
